Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PRECIGEN, INC.PGEN · Entity 4356 | VP, Finance and Accounting | April 21, 2021 | May 06, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PRECIGEN, INC.
Report date April 21, 2021 · Filed May 06, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option to Purchase Common Stock (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.17 · Expires 2031-04-21 | Direct | 30,000 |
Reported balance
After 2021-04-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-04-21 · Grant · Acquired 30,000 · Balance 30,000 F1: The option vests in four equal installments on each of April 21, 2022, April 21, 2023, April 21, 2024 and April 21, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests in four equal installments on each of April 21, 2022, April 21, 2023, April 21, 2024 and April 21, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 21, 2021 Filed May 6, 2021 22:37 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $8.17 | $0.00 |
DisclosureSEC source: 0000950103-21-006869 · dp150710_4-bradford.xml · derivative · entry 1 Osborne D. Bradford · CIK 0001859854 · VP, Finance and Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2031-04-21 F1 · derivative.exercise_date: The option vests in four equal installments on each of April 21, 2022, April 21, 2023, April 21, 2024 and April 21, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.